Genitourinary Syndrome of Menopause: How Social Media can Elevate your Soap Box

Saturday, September 17, 2022

5:00 PM – 6:00 PM East Coast USA Time

Location: JW Grand Ballroom 8

CE: 1

Reference 1: Anger, Jennifer, et al. "Recurrent uncomplicated urinary tract infections in women: AUA/CUA/SUFU guideline." The Journal of urology 202.2 (2019): 282-289.
Reference 2: Portman, David J., Margery LS Gass, and Vulvovaginal Atrophy Terminology Consensus Conference Panel. "Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society." Climacteric 17.5 (2014): 557-563.
Reference 3: Simon, James A., et al. "The role of androgens in the treatment of genitourinary syndrome of menopause (GSM): International Society for the Study of Women's Sexual Health (ISSWSH) expert consensus panel review." Menopause 25.7 (2018): 837-847.

Non-Member Speaker(s)

Rachel S. Rubin, MD

Assistant Clinical Professor in Urology
Georgetown University
Georgetown University

Disclosure(s): Absorption Pharmaceuticals: Board Member/Advisory Panel (Ongoing); Endo Pharmacueticals: Consultant (Ongoing); Sprout: Consultant (Ongoing)

Slides

Disclosure(s):

Rachel S. Rubin, MD: Absorption Pharmaceuticals: Board Member/Advisory Panel (Ongoing); Endo Pharmacueticals: Consultant (Ongoing); Sprout: Consultant (Ongoing)

Learning Objectives:

Re-frame how we think about GSM – that it’s a urologic condition
Discuss a paradigm shift – not just about lubricants and moisturizers but local hormones that prevent urinary tract infections.
Discuss practical dosing to treat GSM.
Arm you with tools to properly educate patients and help with adherence to treatment